BRCA1

Dr. Patrick Sung, PhD back at University of Texas Health Science Center & Attracts $20.9m for Cancer Research

Nov 18, 2019 | BRCA1, BRCA2, Cancer, Investigator Content, Oncology, Sung, Patrick Ph.D. Content

Patrick Sung, PhD, who left Yale University, was recruited back to the University of Texas Health Science Center, San Antonio in 2019. A cancer biologist, he hopes to translate the knowledge of genetic mutations, such as BRCA1 and 2, into better clinical care for...

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

159 WEST BROADWAY SUITE 200
SALT LAKE CITY, UT 84101

Dr. Patrick Sung, PhD back at University of Texas Health Science Center & Attracts $20.9m for Cancer Research

Pin It on Pinterest